Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909075 · ClinicalTrials.gov registry record
A Study to Assess Thymic Function Using PET/CT and MRI
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT02909075: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02909075 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909075 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and after the participants transplantation.
Primary Outcome
A clinically meaningful change is defined as increase in thymic size (\> 0.2cm increase in uni-dimensional diameter), functional volume (\>10%) or uptake (≥25%). We will report proportion of patients with each component of clinically meaningful change, as well as the proportion with at least one component, along 95% exact confidence intervals.
Interventions
- DEVICE MRI
- DEVICE PET/CT scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-01 |
What the finished NCT02909075 record still lists
NCT02909075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02909075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02909075 about?
NCT02909075 is a clinical study titled "A Study to Assess Thymic Function Using PET/CT and MRI". The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and aft...
What is the current status of trial NCT02909075?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2016-08. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02909075?
The interventions under investigation include: MRI (DEVICE), PET/CT scans (DEVICE).
Who is sponsoring clinical trial NCT02909075?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia